Immunological Characteristics of a Patient With Belatacept-Resistant Acute Rejection After Face Transplantation

N Krezdorn; N Murakami; B Pomahac; L V Riella

doi:10.1111/ajt.13977

Immunological Characteristics of a Patient With Belatacept-Resistant Acute Rejection After Face Transplantation

Am J Transplant. 2016 Nov;16(11):3305-3307. doi: 10.1111/ajt.13977. Epub 2016 Aug 26.

Authors

N Krezdorn^{1

2}, N Murakami³, B Pomahac¹, L V Riella⁴

Affiliations

¹ Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
² Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
³ Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
⁴ Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. [email protected].

No abstract available

Keywords: T cell biology; clinical research/practice; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: belatacept; immunobiology; immunosuppressant; immunosuppression/immune modulation; immunosuppressive regimens; maintenance; rejection: acute; side effects; vascularized composite and reconstructive transplantation.

Publication types

Case Reports
Letter
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Abatacept / administration & dosage
Abatacept / adverse effects*
Acute Disease
Drug Resistance*
Facial Transplantation*
Graft Rejection / drug therapy
Graft Rejection / immunology*
Graft Survival
Humans
Immunity, Cellular
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Male
T-Lymphocytes / cytology*

Substances

Immunosuppressive Agents
Abatacept

Grants and funding

T32 DK007527/DK/NIDDK NIH HHS/United States